Johns Hopkins Medicine: DNA Shed From Colon Cancers Into Bloodstream Guide Chemotherapy
June 06, 2022
June 06, 2022
BALTIMORE, Maryland, June 6 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
* * *
Helps clarify the benefit of chemotherapy in stage II cancers
* * *
A new research study showed that circulating tumor DNA (ctDNA) -- genetic material shed from tumors into the bloodstream -- can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of . . .
* * *
Helps clarify the benefit of chemotherapy in stage II cancers
* * *
A new research study showed that circulating tumor DNA (ctDNA) -- genetic material shed from tumors into the bloodstream -- can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery and spare other patients the need for this form of . . .